Hiroshi Uchi

8.0k total citations
215 papers, 5.6k citations indexed

About

Hiroshi Uchi is a scholar working on Dermatology, Oncology and Molecular Biology. According to data from OpenAlex, Hiroshi Uchi has authored 215 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Dermatology, 72 papers in Oncology and 52 papers in Molecular Biology. Recurrent topics in Hiroshi Uchi's work include CAR-T cell therapy research (31 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Toxic Organic Pollutants Impact (24 papers). Hiroshi Uchi is often cited by papers focused on CAR-T cell therapy research (31 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Toxic Organic Pollutants Impact (24 papers). Hiroshi Uchi collaborates with scholars based in Japan, China and United States. Hiroshi Uchi's co-authors include Masutaka Furue, Takeshi Nakahara, Yoichi Moroi, Gaku Tsuji, Chikage Mitoma, Masakazu Takahara, Takamichi Ito, Takahito Chiba, Saori Morino‐Koga and Tetsuya Koga and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Hiroshi Uchi

204 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Uchi Japan 45 1.8k 1.6k 1.5k 1.4k 720 215 5.6k
Chikako Nishigori Japan 39 1.9k 1.0× 1.0k 0.6× 2.3k 1.6× 1.3k 0.9× 452 0.6× 291 6.1k
Jörg Reichrath Germany 48 2.1k 1.2× 901 0.6× 1.6k 1.1× 1.0k 0.7× 903 1.3× 215 6.8k
Chee‐Yin Chai Taiwan 46 582 0.3× 2.1k 1.3× 3.3k 2.2× 1.4k 1.0× 1.2k 1.7× 400 8.9k
Fujio Otsuka Japan 30 1.2k 0.7× 825 0.5× 2.0k 1.3× 1.4k 1.0× 668 0.9× 178 5.4k
Marc Pallardy France 41 708 0.4× 440 0.3× 1.3k 0.9× 1.7k 1.2× 181 0.3× 169 4.6k
James Varani United States 43 1.7k 1.0× 856 0.5× 2.5k 1.7× 1.3k 1.0× 339 0.5× 123 7.1k
Carsten Geisler Denmark 50 2.0k 1.1× 1.7k 1.1× 2.3k 1.5× 4.0k 2.9× 928 1.3× 297 8.6k
Gaku Tsuji Japan 36 2.1k 1.2× 312 0.2× 760 0.5× 1.2k 0.8× 239 0.3× 121 3.8k
Charlotte Esser Germany 38 694 0.4× 281 0.2× 1.4k 1.0× 2.2k 1.6× 212 0.3× 101 5.2k
Akihiro Kimura Japan 32 233 0.1× 1.3k 0.8× 1.7k 1.1× 3.6k 2.6× 514 0.7× 57 6.5k

Countries citing papers authored by Hiroshi Uchi

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Uchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Uchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Uchi more than expected).

Fields of papers citing papers by Hiroshi Uchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Uchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Uchi. The network helps show where Hiroshi Uchi may publish in the future.

Co-authorship network of co-authors of Hiroshi Uchi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Uchi. A scholar is included among the top collaborators of Hiroshi Uchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Uchi. Hiroshi Uchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujisawa, Yasuhiro, Kenjiro Namikawa, Koji Yoshino, et al.. (2025). Phase II trial dedicated to non-selected, pretreated cutaneous angiosarcoma: Efficacy of nivolumab (AngioCheck Study). European Journal of Cancer. 224. 115537–115537. 1 indexed citations
2.
Fujisawa, Yasuhiro, Yasuo Yoshioka, Koji Yoshino, et al.. (2025). Secondary Publication of Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Angiosarcoma 2025. The Journal of Dermatology. 52(10). e859–e875. 1 indexed citations
3.
Yokota, Kenji, Tatsuya Takenouchi, Yasuhiro Fujisawa, et al.. (2024). Long‐term follow‐up results from KEYNOTE‐041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma. The Journal of Dermatology. 51(5). 632–642. 1 indexed citations
4.
5.
Fujisawa, Yasuhiro, Takamichi Ito, Hiroshi Kato, et al.. (2021). Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 cases. European Journal of Cancer. 145. 210–220. 33 indexed citations
6.
Yano, Seiichi, Kenji Ashida, Naoko Wada, et al.. (2019). A Case of Acute Exacerbation of Chronic Adrenal Insufficiency Due to Ipilimumab Treatment for Advanced Melanoma. American Journal of Case Reports. 20. 106–110. 5 indexed citations
7.
Otsuka, Atsushi, Masahiro Hirata, Tatsuki R. Kataoka, et al.. (2019). Variable indoleamine 2,3‐dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy. Cancer Science. 110(11). 3434–3441. 13 indexed citations
8.
Yamazaki, Naoya, Yoshio Kiyohara, Hisashi Uhara, et al.. (2019). Long‐term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma. Cancer Science. 110(6). 1995–2003. 28 indexed citations
9.
Uchi, Hiroshi, et al.. (2018). Perillaldehyde Inhibits AHR Signaling and Activates NRF2 Antioxidant Pathway in Human Keratinocytes. Oxidative Medicine and Cellular Longevity. 2018(1). 9524657–9524657. 54 indexed citations
10.
Tanaka, Yuka, Hiroshi Uchi, Akiko Hashimoto‐Hachiya, & Masutaka Furue. (2018). Tryptophan Photoproduct FICZ Upregulates IL1A, IL1B, and IL6 Expression via Oxidative Stress in Keratinocytes. Oxidative Medicine and Cellular Longevity. 2018(1). 9298052–9298052. 31 indexed citations
11.
Uchi, Hiroshi, et al.. (2016). Inhibition of aryl hydrocarbon receptor signaling and induction of NRF2-mediated antioxidant activity by cinnamaldehyde in human keratinocytes. Journal of Dermatological Science. 85(1). 36–43. 64 indexed citations
12.
Mitoma, Chikage, et al.. (2015). Verruciform xanthoma developing in eroded skin of recessive dystrophic epidermolysis bullosa. European Journal of Dermatology. 25(5). 509–510. 4 indexed citations
13.
Nakahara, Takeshi, Chikage Mitoma, Akiko Hashimoto‐Hachiya, et al.. (2015). Antioxidant Opuntia ficus-indica Extract Activates AHR-NRF2 Signaling and Upregulates Filaggrin and Loricrin Expression in Human Keratinocytes. Journal of Medicinal Food. 18(10). 1143–1149. 40 indexed citations
14.
Fukushi, Jun‐ichi, Shoji Tokunaga, Yasuharu Nakashima, et al.. (2015). Effects of dioxin-related compounds on bone mineral density in patients affected by the Yusho incident. Chemosphere. 145. 25–33. 21 indexed citations
15.
Ito, Takamichi, et al.. (2014). Narrow‐margin excision is a safe, reliable treatment for well‐defined, primary pigmented basal cell carcinoma: an analysis of 288 lesions in Japan. Journal of the European Academy of Dermatology and Venereology. 29(9). 1828–1831. 30 indexed citations
16.
Takahara, Masakazu, Tomoko Saito, Takeshi Nakahara, et al.. (2013). Two Cases of Pemphigoid Nodularis. The Nishinihon Journal of Dermatology. 75(2). 129–133. 1 indexed citations
17.
Uchi, Hiroshi, et al.. (2012). A Case of Fournier's Gangrene Occurring after Removal of a Fish Bone. The Nishinihon Journal of Dermatology. 74(2). 158–160. 1 indexed citations
18.
Uchi, Hiroshi, et al.. (2010). Using the Japanese Version of Skindex-16 and DLQI to Measure the QOL of New Outpatients with Atopic Dermatitis. 120(1). 45–54. 1 indexed citations
19.
Uchi, Hiroshi, et al.. (2009). Quality of Life in Patients with Atopic Dermatitis. Skin research. 8(12). 680–686. 20 indexed citations
20.
Uchi, Hiroshi, Rodica Stan, Mary Jo Turk, et al.. (2006). Unraveling the Complex Relationship Between Cancer Immunity and Autoimmunity: Lessons from Melanoma and Vitiligo. Advances in immunology. 90. 215–241. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chikako Nishigori Breakdown of academic impact, for papers by Jörg Reichrath Breakdown of academic impact, for papers by Chee‐Yin Chai Breakdown of academic impact, for papers by Fujio Otsuka Breakdown of academic impact, for papers by Marc Pallardy Breakdown of academic impact, for papers by James Varani Breakdown of academic impact, for papers by Carsten Geisler Breakdown of academic impact, for papers by Gaku Tsuji Breakdown of academic impact, for papers by Charlotte Esser Breakdown of academic impact, for papers by Akihiro Kimura
Rankless by CCL
2026